Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBRISENTAN vs SPARSENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMBRISENTAN vs SPARSENTAN: Safety Overview

Metric AMBRISENTAN SPARSENTAN
Total FAERS Reports 86,197 3,280
Deaths Reported 10,291 18
Death Rate 11.9% 0.5%
Hospitalizations 32,910 209
Average Patient Age 59.5 yrs 49.3 yrs
% Female Patients 76.1% 43.8%
FDA Approval Date Apr 10, 2019 Feb 17, 2023
Manufacturer Sigmapharm Laboratories, LLC Travere Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription